The FDA has accepted for review the New Drug Application for SYD-101 (atropine sulfate) to slow the progression of myopia in children.
Hemel Today on MSN11h
Myth busting: The truth about cataractsCataracts are one of the most common reasons for vision loss in adults – but they’re also one of the most misunderstood eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback